BioNexus Gene Lab - 2 Year Stock Price History | BGLC
- The all-time high BioNexus Gene Lab stock closing price was 5.95 on July 21, 2023.
- The BioNexus Gene Lab 52-week high stock price is 1.20, which is 224.3% above the current share price.
- The BioNexus Gene Lab 52-week low stock price is 0.21, which is 43.2% below the current share price.
- The average BioNexus Gene Lab stock price for the last 52 weeks is 0.47.
BioNexus Gene Lab Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 0.3777 | 0.3990 | 0.4607 | 0.3270 | 0.3710 | 32.64% |
2024 | 0.4968 | 0.5222 | 1.5700 | 0.2289 | 0.2797 | -47.23% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.007B | $0.010B |
BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $151.685B | 28.04 |
Elevance Health (ELV) | United States | $90.559B | 11.84 |
Cencora (COR) | United States | $47.572B | 17.32 |
Natera (NTRA) | United States | $23.122B | 0.00 |
DiDi Global (DIDIY) | China | $22.844B | 0.00 |
ICON (ICLR) | Ireland | $16.164B | 14.40 |
Avantor (AVTR) | United States | $14.769B | 22.14 |
Revvity (RVTY) | United States | $14.502B | 24.32 |
BioMerieux (BMXMF) | France | $14.256B | 0.00 |
Viatris (VTRS) | United States | $13.010B | 4.01 |
Solventum (SOLV) | United States | $12.919B | 0.00 |
CochLear (CHEOY) | Australia | $12.848B | 0.00 |
Medpace Holdings (MEDP) | United States | $11.220B | 31.61 |
Doximity (DOCS) | United States | $10.877B | 56.56 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $10.037B | 0.00 |
HealthEquity (HQY) | United States | $9.712B | 48.73 |
Sonic Healthcare (SKHHY) | Australia | $8.513B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.502B | 16.43 |
Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
Bausch + Lomb (BLCO) | Canada | $5.661B | 26.33 |
BrightSpring Health Services (BTSG) | United States | $3.913B | 83.22 |
Sotera Health (SHC) | United States | $3.909B | 20.91 |
Organon (OGN) | United States | $3.835B | 3.87 |
Surgery Partners (SGRY) | United States | $3.260B | 37.17 |
Concentras Parent (CON) | United States | $2.958B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.885B | 0.00 |
PACS (PACS) | United States | $2.161B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.121B | 0.00 |
Teladoc Health (TDOC) | United States | $2.061B | 0.00 |
Progyny (PGNY) | United States | $1.859B | 37.64 |
GoodRx Holdings (GDRX) | United States | $1.837B | 48.20 |
Premier (PINC) | United States | $1.821B | 11.08 |
GeneDx Holdings (WGS) | United States | $1.708B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
Agilon Health (AGL) | United States | $1.351B | 0.00 |
CareDx (CDNA) | United States | $1.217B | 0.00 |
Pediatrix Medical (MD) | United States | $1.177B | 11.51 |
Embecta (EMBC) | United States | $1.031B | 7.06 |
AMN Healthcare Services Inc (AMN) | United States | $0.993B | 6.72 |
Establishment Labs Holdings (ESTA) | $0.848B | 0.00 | |
Auna S.A (AUNA) | Luxembourg | $0.602B | 0.00 |
SBC Medicals (SBC) | United States | $0.533B | 0.00 |
DocGo (DCGO) | United States | $0.501B | 18.89 |
Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
InnovAge Holding (INNV) | United States | $0.435B | 0.00 |
Enhabit (EHAB) | United States | $0.414B | 35.83 |
QDM (QDMI) | Hong Kong, SAR China | $0.382B | 10.00 |
MultiPlan (MPLN) | United States | $0.352B | 0.00 |
Nutex Health (NUTX) | United States | $0.323B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.317B | 0.00 |
LifeMD (LFMD) | United States | $0.270B | 0.00 |
Beauty Health (SKIN) | United States | $0.201B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
Sera Prognostics (SERA) | United States | $0.159B | 0.00 |
Biodesix (BDSX) | United States | $0.151B | 0.00 |
So-Young (SY) | China | $0.104B | 17.63 |
Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
Oncology Institute (TOI) | United States | $0.067B | 0.00 |
ModivCare (MODV) | United States | $0.062B | 3.35 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
OncoCyte (OCX) | United States | $0.035B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
Pheton Holdings (PTHL) | China | $0.019B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
KindlyMD (KDLY) | United States | $0.007B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |